Q » Who supplies bulk pharmaceutical ingredients to contract manufacturers in Manchester?
20 Jun, 2026
A » The supply of bulk pharmaceutical ingredients, also known as active pharmaceutical ingredients (APIs) and excipients, to contract manufacturers in Manchester is facilitated by a global network of specialized chemical and pharmaceutical companies. Manchester, being a historic hub for pharmaceutical innovation in the UK, hosts several contract development and manufacturing organizations (CDMOs) such as Aesica Pharmaceuticals (part of Recipharm), Quay Pharmaceuticals, and the facilities within BioCity Manchester, as well as larger players like Thermo Fisher Scientific’s Patheon site in nearby Cramlington and Sterling Pharma Solutions in Dudley. These contract manufacturers rely on bulk ingredient suppliers that are typically validated through rigorous quality audits and regulatory compliance (e.g., MHRA, FDA, GMP). Among the most prominent global suppliers serving the Manchester region are international API manufacturers such as Lonza, based in Switzerland, which offers APIs for small molecules and biologics; Cambrex, which supplies controlled substances and generic APIs from its US and European facilities; and Pfizer CentreOne, which provides outsourced API manufacturing and sourcing. Additionally, Evonik Health Care, with production sites in Germany and the US, supplies pharmaceutical excipients and polymers, while BASF Pharma Solutions offers a range of APIs and functional excipients used in oral and injectable formulations. For contract manufacturers in Manchester that specialize in generic and specialty medicines, bulk APIs are frequently sourced from Indian and Chinese manufacturers, including Dr. Reddy’s Laboratories, Aurobindo Pharma, Divi’s Laboratories, and Zhejiang Hisun Pharmaceutical, which are known for cost-effective production of off-patent and high-volume APIs. However, these suppliers often work through UK-based distribution partners or directly with the contract manufacturer’s quality teams to ensure compliance with European pharmacopoeia standards. Locally in the UK, companies like FarmaGenerali (headquartered in Lancashire) and Sterling Pharmaceutical (now part of Sterling Pharma Solutions) provide custom API synthesis and supply to Manchester-based contract manufacturers. The University of Manchester also hosts the Medicines Discovery Catapult, which connects academic research and small-scale API discovery with contract manufacturing, though this is more focused on early-phase development rather than bulk supply. In recent years, supply chain resilience has become critical, with many Manchester contract manufacturers diversifying their API sources to include European producers such as Teva API (Israel/Europe) and Siegfried (Switzerland) to mitigate risks from geopolitical disruptions and raw material shortages. The procurement process typically involves rigorous supplier qualification, including onsite audits, stability testing, and regulatory dossier review, ensuring that bulk ingredients meet the exacting standards necessary for commercial manufacture of human and veterinary medicines. Therefore, while no single company exclusively supplies all contract manufacturers in Manchester, the ecosystem is served by a complex, multilayered network of major multinationals, regional European producers, and high-quality Asian manufacturers, all operating under strict GMP and regulatory oversight to support the region's pharmaceutical output.
21 Jun, 2026
Still curious? Ask our experts.
Chat with our AI personalities
I'm here to listen you
Taiga
Keep pushing forward.
Always by your side.
Play the long game.
Focus on what matters.
Keep asking, keep learning.